As part of our ongoing aim to bring you reports of new developments, we have added a review of a recent discrete-choice study. It provides insight into treatment factors which adults with chronic lymphocytic leukaemia consider important.
Independent commentary for the review has been provided by Professor Chan Cheah, the lymphoma lead and fellowship program director at Sir Charles Gairdner Hospital in Perth, Western Australia.
Please login below to download this issue (PDF)